29 Amendments of Radan KANEV related to 2023/2075(INI)
Amendment 58 #
Motion for a resolution
Recital B
Recital B
B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in Europe; whereas other NCDs include mental and neurological disorders, liver diseases , kidney diseases, oral diseases, Rheumatic and Musculoskeletal Diseases (RMDs), including osteoporosis, osteoarthritis and endometriosis among other conditions;
Amendment 142 #
Motion for a resolution
Recital F a (new)
Recital F a (new)
Fa. whereas there is a firmly scientifically established link between certain communicable diseases and NCDs, and especially types of cancer, caused by either viral or bacterial infections;
Amendment 148 #
Motion for a resolution
Recital F b (new)
Recital F b (new)
Fb. whereas such interconnections between communicable diseases and NCDs might exist in many other cases and much still has to be learned about the effect of communicable diseases on non- communicable diseases, including severe post-viral conditions such as post- COVID-19 conditions;
Amendment 152 #
Motion for a resolution
Recital F c (new)
Recital F c (new)
Fc. whereas the COVID-19 pandemic shed light on the serious phenomenon of comorbidity and comortality when communicable diseases reach patients with NCDs;
Amendment 154 #
Motion for a resolution
Recital F d (new)
Recital F d (new)
Fd. whereas the interconnections between communicable diseases and NCDs have been poorly studied in the recent decades, mainly due to insufficient funding for research and lack of systematized epidemiological, statistical and other scientific data;
Amendment 155 #
Motion for a resolution
Recital F e (new)
Recital F e (new)
Fe. whereas REGULATION (EU) 2022/2370 of 23 November 2022 amending Regulation (EC) No 851/2004 establishing a European centre for disease prevention and control explicitly obliges the Commission to address the impact of cross-border threats to health on non-communicable diseases through an independent external evaluation;
Amendment 158 #
Motion for a resolution
Recital G
Recital G
G. whereas improved evidence-based health promotion and disease prevention can reduce the prevalence of NCDs by as much as 70 %7 ; _________________ 7 European Commission, ‘Healthier together – EU non-communicable diseases initiative’, p. 15, June 2022., without prejudice to the further positive effect of new in-depth research and studies of the interconnections between communicable and non-communicable diseases;
Amendment 168 #
Motion for a resolution
Recital G a (new)
Recital G a (new)
Ga. whereas new studies of the interconnection of communicable and non-communicable diseases will greatly improve both prevention and diagnosis of NCDs;
Amendment 183 #
Motion for a resolution
Recital H
Recital H
H. whereas innovation with regard to development of technologies, medicines and healthcare practises, and harm reduction policies is crucial to ensure the elimination or reduction of harm caused by preventable risk factors and new and better treatments for NCDs;
Amendment 218 #
Motion for a resolution
Paragraph 1 a (new)
Paragraph 1 a (new)
1a. Reiterates, that financing for new research and studies and ensuring the systematization and study of comprehensive epidemiological, statistical and other scientific data on NCDs and their interconnection with communicable diseases can shed new light on the causes of various NCDs, including defining new behavioural and environmental risks;
Amendment 225 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme and the Commission Communication entitled ‘A comprehensive approach to mental health’; calls on the Commission to strengthen the ‘Healthier together – EU NCD’ initiative by introducing a holistic EU strategy on NCDs complemented by action plans for specific NCDs; welcomes national plans and actions already taken against NCDs by Member States; believes however that a special cardiovascular strategy is needed in the light of cardiovascular disease being the number one cause of death in the Union;
Amendment 265 #
Motion for a resolution
Paragraph 3 a (new)
Paragraph 3 a (new)
3a. Acknowledges the complex and multifactorial causes of NCDs and that NCDs cannot always be prevented, and that even among preventable NCDs, there are many cases that cannot be explained by preventable risk factors and that many NCDs display a high degree of hereditary risk;
Amendment 295 #
Motion for a resolution
Paragraph 5 – point a
Paragraph 5 – point a
a. implement measures to help tobacco users quit, reduce the rate of new tobacco users, and prevent tobacco use among minors;
Amendment 318 #
Motion for a resolution
Paragraph 5 – point b a (new)
Paragraph 5 – point b a (new)
Amendment 350 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Acknowledges that the harmful use of alcohol is a risk factor for multiple NCDs and underlines that the lower the amount of alcohol consumed, the lowera higher consumption of alcohol increases the risk is of developing NCDs14 ; _________________ 14 Global burden of disease 2016 Alcohol Collaborators, ‘Alcohol use and burden for 195 countries and territories,1990–2016: a systematic analysis for the Global Burden of Disease Study 2016’, 23 August 2018.
Amendment 402 #
Motion for a resolution
Paragraph 8 – point a
Paragraph 8 – point a
a. encourage and help consumers to make informed and healthy choices about food products; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy and sustainable diets; mainstream physical activities such as walking, cycling, and the practice of sports in urban planning, and put an increased emphasis on physical activity in schools;
Amendment 511 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Regrets the slowCalls on the Commission to continuously implementation of the Chemicals Strategy for Sustainability, and, in particular, expects the REACH Regulation18 to be revised, including in line with the Better Regulation principles, in order to be able to identify all substances of concern manufactured or imported in the EU; _________________ 18 Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), OJ L 396, 30.12.2006, p. 1.
Amendment 519 #
Motion for a resolution
Paragraph 13 a (new)
Paragraph 13 a (new)
13a. Acknowledges, however, that many NCDs could not be attributed, or could only partially be attributed to behavioural and environmental factors;
Amendment 523 #
Motion for a resolution
Paragraph 13 b (new)
Paragraph 13 b (new)
13b. Regrets the lack of sufficient public funding and incentives for private investment for scientific research on the interconnection between communicable and non-communicable diseases, the failure to ensure the systematization of scientific data on these interconnections and promote early diagnostics, vaccination and/or treatment of communicable diseases, leading to NCDs;
Amendment 528 #
Motion for a resolution
Paragraph 13 c (new)
Paragraph 13 c (new)
13c. Reiterates the need for further study of the impact of communicable diseases on patients with NCDs and of the various so-called post-viral conditions and possible links between such chronic conditions as ME/CFS and previous communicable infections;
Amendment 541 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes in this regard such as in the fight against human papillomavirus transmission, hepatitis and bacterial infections leading to stomach cancer;
Amendment 556 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Highlights the importance of identifying people with a high risk of developing NCDs and diagnosing people as early as possible to improve disease management, prevent complications and save downstream costs for healthcare systems; calls for the systematic exchange at the European level of best practice regarding screening for and early detection of NCDs, such as prostate and cervical cancer; welcomes the updated Council recommendation on cancer screening and calls on Member States to implement it diligently;
Amendment 603 #
Motion for a resolution
Paragraph 17 a (new)
Paragraph 17 a (new)
17a. Highlights the link between oral health, including pariodental disease and caries, and some NCDs, such as diabetes and cardiovascular diseases, and the potential positive effects on NCDs of improved oral health;
Amendment 662 #
Motion for a resolution
Paragraph 19 a (new)
Paragraph 19 a (new)
19a. Notes that NCDs can have a significant negative effect on mental health, and stresses the need for integrated healthcare for concerned patients; stresses that negative stereotypes related to certain NCDs, notably obesity, can be counterproductive in healthcare and prevention while recalling individual responsibility for certain risk factors;
Amendment 756 #
Motion for a resolution
Paragraph 23
Paragraph 23
23. Highlights the potential of the private sector with respect to disease control and healthcare; Welcomes public- private partnerships as a way of strengthening innovation in healthcare; highlights the European Health Innovation Collaborative, which promotes entrepreneurship and innovation in the healthcare sector and brings together academia, research, and industry to foster collaboration and investment in health technologies; encourages the Commission and the Member States to foster and accelerate public-private partnerships;
Amendment 765 #
Motion for a resolution
Paragraph 24
Paragraph 24
24. Calls on the Commission to strengthen support and investment in the development of new innovative medical devices; believes that new technologies can lead to new and better treatments for NCDs; notes the slow uptake of medical devices under the current Medical Devices Regulation and In Vitro Diagnostic Devices Regulation, and welcomes the postponement of application of certain provisions; calls on the Commission to evaluate the specific needs for the pediatric and orphan medical devices sectors, and propose any legislative amendments necessary to ensure the continuous supply for these patient groups;
Amendment 792 #
Motion for a resolution
Paragraph 25
Paragraph 25
25. Believes that improving knowledge, systematization of scientific data and sharing of evidence-based best practices among Member States is needed to accelerate effective prevention measures and innovative practices;
Amendment 806 #
Motion for a resolution
Paragraph 26
Paragraph 26
26. Calls on the Commission to establish fivprepare EU NCD partnerships: ‘beating NCDs – children’, ‘beating NCDs – young, based on diseases or people, ‘beating NCDs – adults’, ‘beating NCDs – elderly people’ and ‘beating NCDs – vulnerable groups’ulation groups, as appropriate; believes that such partnerships shcould bring together Member States and national authorities to draft roadmaps and innovative proposals to ensure effective and targeted actions against NCDs;
Amendment 821 #
Motion for a resolution
Paragraph 27
Paragraph 27
27. Calls on the Commission to create a European NCD Health Knowledge Centre to improve data collection and research on NCDs and links between NCDs and communicable diseases; stresses the need for further research in NCD co-morbidities and management;